Why the study?
Are nitrates, beta blockers, and calcium antagonists effective in the treatment of stable angina pectoris?
Are nitrates, beta blockers, and calcium antagonists effective in the treatment of stable angina pectoris?
This review summarizes the efficacy, mechanisms, and rationale for using nitrates, beta blockers, and calcium antagonists, alone or in combination, for stable angina pectoris.
Supports established antianginal therapies; leaves open need for updated RCTs on optimal combinations.
Numerous controlled studies have shown that nitrates, beta blockers, and calcium antagonists are effective in the treatment of stable angina pectoris. The pharmacokinetics, pharmacodynamics, and hemodynamic effects of these agents are different, and thus combination therapy offers additive improvement and also counterbalancing of the undesirable side effects of each drug. The choice of therapy depends on the severity of symptoms, associated diseases, compliance, side effects, and status of left ventricular function. The main mechanism of improvement is a decrease in myocardial oxygen consumption, though an increase in coronary blood flow is another potential reason for the use of calcium blockers. This review considers the properties of these drugs, their mechanism of action, and the results of randomized studies.
No takes yet. Share an insight, caveat, or question.
Chan et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: